{"transactions":[{"id":4620865,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-17T20:05:05.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":2095,"price":5.49,"value":11501.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":68717,"source":{"system":"sec-edgar","filing":"0001193125-26-394325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022626/000119312526394325/ownership.xml","form_type":"4"}},{"id":4620287,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-09-17T00:03:12.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."}],"balance_after":471,"derivative":{"underlying":"Common Stock","underlying_shares":471},"source":{"system":"sec-edgar","filing":"0001852880-26-000002","document":"wk-form4_1789603389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000185288026000002/wk-form4_1789603389.xml","form_type":"4"}},{"id":4620286,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-17T00:03:12.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":1187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."}],"balance_after":1187,"derivative":{"exercise_price":340.03,"expiration_date":"2036-09-13","underlying":"Common Stock","underlying_shares":1187},"source":{"system":"sec-edgar","filing":"0001852880-26-000002","document":"wk-form4_1789603389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000185288026000002/wk-form4_1789603389.xml","form_type":"4"}},{"id":734513,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:05:12.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":2095,"price":6.1,"value":12779.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":70812,"source":{"system":"sec-edgar","filing":"0001193125-26-274125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022626/000119312526274125/ownership.xml","form_type":"4"}},{"id":838577,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-17T21:00:45.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":2093,"price":9.29,"value":19443.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":72907,"source":{"system":"sec-edgar","filing":"0001193125-26-111124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022626/000119312526111124/ownership.xml","form_type":"4"}},{"id":947292,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:15:02.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest in forty-eight equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":27.07,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001193125-26-004754","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2022626/000119312526004754/ownership.xml","form_type":"4"}},{"id":947291,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-06T22:15:02.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2024 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting. The RSUs shall vest in sixteen equal quarterly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001193125-26-004754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022626/000119312526004754/ownership.xml","form_type":"4"}},{"id":1099359,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-30T22:18:43.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2025 and vest in equal monthly tranches over a one-year period."}],"balance_after":5000,"derivative":{"exercise_price":137.46,"expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001852880-25-000003","document":"wk-form4_1751321917.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000185288025000003/wk-form4_1751321917.xml","form_type":"4"}},{"id":1278972,"issuer":{"id":5743,"kind":"organization","name":"Upstream Bio, Inc.","symbol":"UPB"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T22:32:21.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in forty-eight equal monthly installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":8.53,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-25-016471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022626/000095017025016471/ownership.xml","form_type":"4"}},{"id":1466008,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T23:24:06.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2024 and vest in equal monthly tranches over a one-year period."}],"balance_after":5000,"derivative":{"exercise_price":183.64,"expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001852880-24-000002","document":"wk-form4_1719876240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000185288024000002/wk-form4_1719876240.xml","form_type":"4"}},{"id":1816580,"issuer":{"id":79644,"kind":"organization","name":"Allakos Inc.","symbol":"ALLK"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-08-03T22:02:48.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":154786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one thirty-sixth (1/36) of the shares monthly over a three year period, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":154786,"derivative":{"exercise_price":5.55,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":154786},"source":{"system":"sec-edgar","filing":"0001209191-23-044533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000120919123044533/doc4.xml","form_type":"4"}},{"id":1839826,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T20:31:24.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2023 and vest in equal monthly tranches over a one-year period."}],"balance_after":6800,"derivative":{"exercise_price":117.4,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001711279-23-000057","document":"wk-form4_1688416274.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000171127923000057/wk-form4_1688416274.xml","form_type":"4"}},{"id":2217473,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T20:18:25.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period."}],"balance_after":6800,"derivative":{"exercise_price":65.66,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001711279-22-000042","document":"wf-form4_165670668078150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000171127922000042/wf-form4_165670668078150.xml","form_type":"4"}},{"id":2421219,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T21:47:06.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on January 31, 2022 and vest in equal monthly tranches over a three-year period."}],"balance_after":13600,"derivative":{"exercise_price":59,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":13600},"source":{"system":"sec-edgar","filing":"0001852880-22-000002","document":"wf-form4_164366560575664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000185288022000002/wf-form4_164366560575664.xml","form_type":"4"}},{"id":2571060,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T23:34:57.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021.  Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 22, 2021. This option will vest as to 25% of the shares on March 22, 2022, and in thirty-six equal monthly installments thereafter as to the remaining shares through March 22, 2025."}],"balance_after":0,"derivative":{"exercise_price":16.37,"expiration_date":"2031-03-22","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-21-056067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000120919121056067/doc4.xml","form_type":"4"}},{"id":2775097,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":37338,"kind":"person","name":"Sutherland Everett Rand","position":1,"cik":"0001852880","reported_name":"Sutherland Everett Rand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-23T20:40:40.000Z","date":"2021-03-22","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% of the shares on March 22, 2022, and in thirty-six equal monthly installments thereafter as to the remaining shares through March 22, 2025."}],"balance_after":300000,"derivative":{"exercise_price":16.37,"expiration_date":"2031-03-22","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-21-022573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852880/000120919121022573/doc4.xml","form_type":"4"}}]}